FEDERAL COURT OF AUSTRALIA
Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd (No 2) [2013]
FCA 279
Citation: Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd (No 2) [2013] FCA 279 Parties: BAYER PHARMA AKTIENGESELLSCHAFT and BAYER AUSTRALIA LIMITED ACN 000 138 714 v GENERIC HEALTH PTY LTD ACN 110 617 859 and LUPIN AUSTRALIA PTY LTD ACN 112 038 105 File number(s): NSD 236 of 2012 Judge: JAGOT J Date of judgment: 4 April 2013 Catchwords: PATENTS – Validity – Infringement – Lack of inventive step – Obviousness – Manner of manufacture – Fair basing Legislation: Patents Act 1990 (Cth)
Therapeutic Goods Act 1989 (Cth)Cases cited: Aktiebolaget Hassle v Alphapharm (2002) 212 CLR 411; [2002] HCA 59
Alpharpharm Pty Ltd v H Lundbeck A/S (2008) 76 IPR 618; (2008) FCA 559
Application of Tomlinson (1966) 363F 2d 928
Bayer Pharma Aktiengelsellschaft v Generic Health Pty Ltd [2013] FCA 226)
Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65
Commissioner of Patents v Microcells Ltd (1959) 102 CLR 323
Lockwood Security Products Pty Ltd v Doric Products Pty Ltd (No 1) (2004) 217 CLR 274; [2004] HCA 58
NationalResearch Development Corporationv Commissioner of Patents (1959) 102 CLR 252
Olin Mathieson Chemical Corporation v Biorex Laboratories Ltd [1970] RPC 157
Populin v HB Nominees Pty Ltd (1982) 41 ALR 471
Pfizer Overseas Pharmaceuticals v Eli Lilly & Co (2005) 5 ALR 416; [2005] FCAFC 224
Wellcome Foundation Ltd v VR Laboratories (Aust) Pty Ltd (1981) 148 CLR 262; [1981] HCA 12Date of hearing: 11 - 14 and 18 - 22 March Place: Sydney Division: GENERAL DIVISION Category: Catchwords Number of paragraphs: 107 Counsel for the First and Second Applicants: D Shavin QC with Helen Rofe Counsel for the First and Second Respondents: A H Bowne SC with A D B Fox Solicitor for the First and Second Applicants: Davies Collison Cave Law Solicitor for the First and Second Respondents: K & L Gates
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
GENERAL DIVISION
NSD 236 of 2012
BETWEEN: BAYER PHARMA AKTIENGESELLSCHAFT
First ApplicantBAYER AUSTRALIA LIMITED ACN 000 138 714
Second ApplicantAND: GENERIC HEALTH PTY LTD ACN 110 617 859
First RespondentLUPIN AUSTRALIA PTY LTD ACN 112 038 105
Second Respondent
JUDGE:
JAGOT J
DATE OF ORDER:
4 APRIL 2013
WHERE MADE:
SYDNEY
THE COURT ORDERS THAT:
1.The parties are to file and serve proposed orders reflecting these reasons for judgment within seven days of the date of these orders.
2.The proceeding is to be listed on a date not less than seven days thereafter such date being determined in consultation with the parties.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
GENERAL DIVISION
NSD 236 of 2012
BETWEEN: BAYER PHARMA AKTIENGESELLSCHAFT
First ApplicantBAYER AUSTRALIA LIMITED ACN 000 138 714
Second ApplicantAND: GENERIC HEALTH…
Keep reading for free
Create a free CaseChat account to read Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd (No... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2013] FCA 279
- Decision Date
CaseChat Overview and Summary
The court found that the patent was valid and that Generic Health had infringed claims 3 and 11 of the patent. The court held that the invention was not merely finding the means to ensure that the API dissolved rapidly, but rather finding a suitable formulation by which the API was bioavailable and not degraded in the stomach. The court found that the expert evidence of Dr Rowe and Professor Davies was more compelling than that of Dr Walters, and that their experience and expertise in formulation supported their opinions that the invention was not obvious. The court also found that the evidence did not support a finding of obviousness on any view.
The court ordered that the parties were to file and serve proposed orders reflecting these reasons for judgment within seven days of the date of the orders, and that the proceeding was to be listed on a date not less than seven days thereafter. The parties were to consult and determine the date in consultation with each other. Entry of orders was to be dealt with in accordance with Rule 39.32 of the Federal Court Rules 2011.
Orders
Orders of the court
1. The parties are to file and serve proposed orders reflecting these reasons for judgment within seven days of the date of these orders.
2. The proceeding is to be listed on a date not less than seven days thereafter such date being determined in consultation with the parties.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.